
Board Meeting29 Oct 2026, 06:31 pm
Dhampure Specialty Sugars Board Meeting on Nov 3 to Approve Q2 Results, Director Appointment
AI Summary
Dhampure Specialty Sugars Ltd has announced a Board of Directors meeting scheduled for November 3, 2026. The primary agenda items include the consideration and approval of the un-audited standalone and consolidated financial statements for the quarter ended September 30, 2026, along with the limited review report. Additionally, the board will consider the appointment of Dr. Ravinder Nath Batta as a Non-Executive Additional Independent Director, effective from November 3, 2026. The company also informed that the trading window for designated persons will remain closed until 48 hours after the declaration of the financial results.
Key Highlights
- Board meeting scheduled for November 3, 2026.
- To approve Q2 FY27 un-audited standalone and consolidated financial results.
- Consideration for appointment of Dr. Ravinder Nath Batta as Independent Director.
- Trading window closure for designated persons announced.
Price Impact
More from DHAMPURE